MindUP Invests in its 14th Portfolio Company: phenofAST prweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prweb.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
HAIFA, Israel, Jan. 19, 2021 /PRNewswire/ MindUP, Israel s first dedicated digital health incubator, is pleased to welcome CogMe to its family of portfolio companies.
CogMe is developing a platform to reduce cognitive drops in populations at risk, initially focusing on delirium, an acute condition that most commonly arises in an inpatient setting. Using AI, CogMe will provide a comprehensive solution that will analyze cognitive and biological indicators of the individual patient to predict, detect and intervene to prevent cognitive drops. Delirium, a prevalent and dangerous sudden state of confusion common in elderly adults, is nearly universally under-recognized and under-treated, noted Liat Feinberg, CEO and co-founder of CogMe. It often leads to a cascade of events that include patient falls, further complications, extended post-acute care and even death. Naturally, these adverse events also increase the cost of care. We believe that